CI Global Health Sciences Corporate Class

Series A USD
 

Fund overview

This fund invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry.

Fund details

description of elementelement value
Inception date July 1996
CAD Total net assets ($CAD)
As at 2024-10-30
$164.9 million
NAVPS
As at 2024-11-20
$38.2137
MER (%)
As at 2024-03-31
2.33
Management fee (%) 1.90
Asset class Sector Equity
Currency USD
Minimum investment $500 initial/$25 additional
Distribution frequency Quarterly
Last distribution $0.7240

Risk rating1

  • Low
  • Low to medium
  • Medium
  • Medium to high
  • High

FUND CODES

A ISC 301
DSC SO* 401
LL SO 1401
F 324
P 90324
*No new purchases directly into switch only funds.

Performance2 As at 2024-10-31

Growth of $10,000 (Since inception date)

growth of 10k graph

Calendar year performance

annual performance graph

average annual compound returns

YTD 1 Mo 3 Mo 6 Mo 1 Y 3 Y 5 Y 10 Y Inception*
1.88% -6.36% -6.23% -0.57% 10.27% -1.02% 5.42% 1.26% 7.66%
*Since inception date

Distribution history3

Payable date Total
2022-03-25 0.7240
2021-03-26 0.2492
2020-12-18 0.3973
2020-09-25 0.3778
2020-06-26 0.2765
Payable date Total
2020-03-20 0.6464
2019-12-13 0.4049
2019-09-27 0.4529
2019-06-21 0.4275
2019-03-22 0.6736

Management team

First we'll display the Team Company and then the Team members
Greg Quickmire
Peter Hofstra

CI Global Health Sciences Corporate Class

Series A USD
 
Portfolio allocations4 As at 2024-10-31
Asset allocation (%)
  • US Equity 80.91
  • International Equity 18.51
  • Cash and Equivalents 0.58
Sector allocation (%)
  • Healthcare 96.10
  • Exchange Traded Fund 2.33
  • Consumer Services 0.99
  • Cash and Cash Equivalent 0.58
Geographic allocation(%)
  • United States 81.37
  • Denmark 7.80
  • United Kingdom 6.47
  • Germany 2.71
  • Switzerland 1.58
  • Canada 0.07
Top holdings
Sector (%)
1. UnitedHealth Group Inc Healthcare Services 10.74%
2. Eli Lilly and Co Drugs 10.67%
3. Novo Nordisk A/S Cl B Drugs 6.85%
4. AstraZeneca PLC Drugs 6.45%
5. AbbVie Inc Drugs 5.53%
6. Merck & Co Inc Drugs 5.48%
7. Zoetis Inc Cl A Drugs 5.14%
8. Thermo Fisher Scientific Inc Healthcare Equipment 4.01%
9. Boston Scientific Corp Healthcare Equipment 3.92%
10. Intuitive Surgical Inc Healthcare Equipment 3.61%
11. Cigna Corp Healthcare Services 3.37%
12. Anthem Inc Healthcare Services 2.90%
13. Abbott Laboratories Healthcare Equipment 2.74%
14. Stryker Corp Healthcare Equipment 2.72%
15. Siemens Healthineers AG Healthcare Equipment 2.71%
Over 35,000 financial advisors have chosen CI Global Asset Management as a partner. We believe that Canadians have the best opportunity for investments success by using the services of a professional financial advisor. Learn more at ci.com.